US Stock MarketDetailed Quotes

PHAR Pharming Group

Watchlist
  • 10.600
  • +0.050+0.47%
Close Dec 26 16:00 ET
719.06MMarket Cap-39.26P/E (TTM)

Pharming Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Pharming Group Q3 2024 Earnings Date

Currency：USDOct 24, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
77.56M
74.85M
-2.71M
Miss Est.
+16.43%
+12.28%
-3.50%
EPS
-<0.01
-0.02
-0.02
Miss Est.
-148.00%
-140.00%
-733.33%
Analyst Rating
Strong Buy

Dec 9, 2024

Pharming Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 60.928M--
--2024/Q4-- / 76.667M--
Oct 24, 20242024/Q369.422M / 69.657M--
Aug 1, 20242024/Q268.462M / 66.479M--
May 8, 20242024/Q151.723M / 65.541M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 60.928M--
--2024/Q4-- / 76.667M--
Oct 24, 20242024/Q369.422M / 69.657M--
Aug 1, 20242024/Q268.462M / 66.479M--
May 8, 20242024/Q151.723M / 65.541M--

Unlock Free Earnings Estimates

Pharming Group Earnings Reports

  • Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 16 06:13 ET

  • Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 24 06:04 ET

  • Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 1 06:12 ET

  • Pharming Group | 6-K: Report of foreign private issuer (related to financial reporting)

    May 8 06:08 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    SilverCrest Metals
    SILV
    +2.40%
    Cars.com
    CARS
    +2.25%
    Lantheus
    LNTH
    +2.14%
    Collegium Pharmaceutical
    COLL
    +1.48%
    Hutchmed (China)
    HCM
    +1.19%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data